Pular para o conteúdo
Merck

Unveiling P. vivax invasion pathways in Duffy-negative individuals.

Cell host & microbe (2023-12-07)
Isabelle Bouyssou, Sara El Hoss, Cécile Doderer-Lang, Matthieu Schoenhals, Lova Tsikiniaina Rasoloharimanana, Inès Vigan-Womas, Arsène Ratsimbasoa, Andargie Abate, Lemu Golassa, Solenne Mabilotte, Pascal Kessler, Micheline Guillotte-Blisnick, Francisco J Martinez, Chetan E Chitnis, John Strouboulis, Didier Ménard
RESUMO

Vivax malaria has long been thought to be absent from sub-Saharan Africa owing to the high proportion of individuals lacking the Duffy antigen receptor for chemokines (DARC) in their erythrocytes. The interaction between P. vivax Duffy-binding protein (PvDBP) and DARC is assumed to be the main pathway used by merozoites to invade reticulocytes. However, the increasing number of reports of vivax malaria cases in genotypically Duffy-negative (DN) individuals has raised questions regarding the P. vivax invasion pathway(s). Here, we show that a subset of DN erythroblasts transiently express DARC during terminal erythroid differentiation and that P. vivax merozoites, irrespective of their origin, can invade DARC+ DN erythroblasts. These findings reveal that a large number of DN individuals may represent a silent reservoir of deep P. vivax infections at the sites of active erythropoiesis with low or no parasitemia, and it may represent an underestimated biological problem with potential clinical consequences in sub-Saharan Africa.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Anti-DARC antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution